Your healthcare provider will typically recommend starting a new medication when your next Zepbound dose would have been due, usually one week after your last injection
Always consult your doctor before starting any new medication or making changes to your treatment plan
2 Verify the pharmacy Ask for the compounding pharmacy's name and confirm its 503A license with the state board of pharmacy
Does a genetic test predict how I will respond to tirzepatide
Its legally prepared by licensed pharmacies under section 503A or 503B of the FDCA for patient-specific use
reliable contraception should be in place, and any plans to conceive should be discussed with a clinician before starting or stopping treatment If you experience any of the following whilst using retatrutide or any weight-loss agent, seek prompt medical attention: Severe or persistent nausea, vomiting, or abdominal pain particularly pain radiating to the back, which may indicate pancreatitis Right upper quadrant pain, jaundice, or fever, which may suggest gallbladder disease Persistent vomiting with reduced urine output or signs of dehydration Signs of low blood sugar (shakiness, sweating, confusion, dizziness) Rapid or irregular heartbeat Unexplained muscle weakness or pain Rash, swelling of the face or throat, or difficulty breathing, which may indicate a serious allergic reaction Retatrutide has no UK marketing authorisation